<DOC>
	<DOCNO>NCT01016275</DOCNO>
	<brief_summary>The objective clinical study evaluate , control setting , long-term ( 24 month ) outcome self-expanding nitinol rapid-exchange Misago ( Terumo ) stent TASC A B iliac lesion .</brief_summary>
	<brief_title>Misago Iliac Study</brief_title>
	<detailed_description />
	<criteria>Patient present stenotic occlusive lesion iliac artery suitable stenting ( indication primary stenting , base discretion investigator ) Patient present score 2 5 follow Rutherford classification Patient willing comply specify followup evaluation specify time duration study Patient &gt; 18 year old Patient ( legal representative ) understand nature procedure provide write informed consent , prior enrolment study Patient eligible treatment Misago ( Terumo ) The target lesion either modify TASCII class A B lesion one list specification : Type A lesion Unilateral bilateral stenosis Common Iliac Artery Unilateral bilateral single short ( ≤3 cm ) stenosis External Iliac Artery Type B lesion Unilateral Common Iliac Artery occlusion Single multiple stenosis total 310 cm involve External Iliac Artery extend Common Femoral Artery Unilateral External Iliac Artery occlusion involve origin Internal Iliac Artery Common Iliac Artery The target lesion angiographic evidence stenosis restenosis &gt; 50 % occlusion pass standard guidewire manipulation There angiographic evidence patent Common Deep Femoral Artery The target lesion either modify TASCII class B lesion aortic lesion involvement : Short ( ≤3 cm ) stenosis infrarenal aorta The target lesion either modify TASCII class C D lesion aortic lesion involvement : Presence aneurysm level iliac artery Previously implant stent ( ) lesion site Reference segment diameter suitable available stent design Untreatable lesion locate distal outflow artery Use alternative therapy ( e.g . atherectomy , cut balloon , laser , radiation therapy ) part index procedure Patients refuse treatment Patients antiplatelet therapy , anticoagulant thrombolytic drug contraindicate Patients exhibit persistent acute intraluminal thrombus propose lesion site Perforation angioplasty site evidence extravasation contrast medium Patients history prior lifethreatening contrast medium reaction Patients know hypersensitivity nickeltitanium Patients uncorrected bleed disorder Female patient child bear potential take adequate contraceptive currently breastfeed Life expectancy less twelve month Any planned surgical intervention/procedure within 30 day study procedure Any patient consider hemodynamically unstable onset procedure Patient currently participate another investigational drug device study complete entire follow period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>To obtain first iliac long-term result patient cohort treat nitinol stent</keyword>
</DOC>